Keyphrases
Confidence Interval
100%
Statins
82%
Netherlands
73%
Pharmacoepidemiology
69%
Myocardial Infarction
56%
Odds Ratio
46%
Drug Use
40%
Antihypertensive Drugs
40%
European Countries
34%
Hazard Ratio
33%
Hip Fracture
31%
Clinical Practice Research Datalink
31%
Clopidogrel
28%
Beta-blockers
28%
Dutch
27%
Atrial Fibrillation
27%
Europe
27%
Acute Myocardial Infarction
27%
Direct Oral Anticoagulants
26%
Antidepressants
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Incidence Rate
25%
Non-inferiority Trial
24%
Polymorphism
24%
Femoral Fractures
23%
Coronary Artery Disease
23%
Stroke Risk
23%
Propensity Score Methods
22%
BIFAP
22%
Confounding
21%
Electronic Health Record Databases
21%
Simulation Study
21%
Noninferiority Margin
21%
Health Technology Assessment
21%
Statin Therapy
20%
Denmark
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Antidepressant Use
20%
Spain
20%
Database Study
20%
Major Bleeding
19%
Hypertension
19%
Genotype
19%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
19%
β2-agonists
18%
Risk Factors
18%
ACE Inhibitors
18%
Randomized Controlled Trial
18%
Calcium Channel Blockers
18%
Primary Care Database
18%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
61%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
57%
Statin (Protein)
57%
Heart Infarction
50%
Prevalence
50%
Cerebrovascular Accident
47%
Antihypertensive Agent
44%
Atrial Fibrillation
40%
Dipeptidyl Carboxypeptidase Inhibitor
39%
Antidepressant
37%
Observational Study
33%
Randomized Controlled Trial
33%
Hip Fracture
31%
Clopidogrel
30%
Case-Control Study
29%
Acute Heart Infarction
29%
Pharmacogenetics
28%
Pharmacotherapy
27%
Antihypertensive Drug
27%
Beta Adrenergic Receptor Blocking Agent
27%
Diseases
27%
Cardiovascular Disease
25%
Direct Oral Anticoagulant
25%
Femur Fracture
24%
Adverse Drug Reaction
24%
Anticoagulant Agent
23%
Calcium Channel Blocker
22%
Noninferiority Trial
22%
Antiplatelet
19%
Diuretics
19%
Mercaptopurine
18%
Bleeding
18%
Brain Ischemia
18%
Pharmacoepidemiology
17%
Inflammatory Bowel Disease
17%
Non Insulin Dependent Diabetes Mellitus
16%
Liver Injury
16%
Non-Steroidal Anti-Inflammatory Drug
16%
Drug Utilization
16%
Rivaroxaban
15%
Antivitamin K
15%
Proton Pump Inhibitor
15%
Angiotensin
15%
Renin
15%
Comorbidity
14%
Congestive Heart Failure
14%
Antithrombocytic Agent
14%
Beta 2 Adrenergic Receptor Stimulating Agent
14%
Malignant Neoplasm
14%
Antilipemic Agent
14%